Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6520987 | 0.82 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1KMT2ARAB9A | |
| SCHEMBL6513794 | 0.81 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1KMT2ANPC1RAB9A | |
| SCHEMBL6515135 | 0.81 | EPHX2 (0.41) | ALDH1A1L3MBTL1GLAMEN1KMT2A | |
| SCHEMBL9355892 | 0.79 | KEAP1 (0.43) | ALDH1A1L3MBTL1CYP2C19EPHX1NPC1 | |
| SCHEMBL7404934 | 0.78 | FKBP1A (0.43) | ALDH1A1MAPK1L3MBTL1FKBP1AEPHX1 | |
| SCHEMBL6516322 | 0.78 | KEAP1 (0.42) | ALDH1A1MAPK1L3MBTL1CYP3A4MEN1 | |
| SCHEMBL6520853 | 0.78 | KMT2A (0.38) | ALDH1A1L3MBTL1EPHX1MEN1KMT2A | |
| SCHEMBL6519861 | 0.78 | L3MBTL1 (0.42) | ALDH1A1L3MBTL1CYP2C19EPHX1NPC1 | |
| SCHEMBL6523907 | 0.77 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1KMT2ANPC1 | |
| SCHEMBL10408164 | 0.77 | ALDH1A1 (0.45) | ALDH1A1MAPK1L3MBTL1FKBP1AEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ALDH1A1 1254/4885MAPK1 1916/4885L3MBTL1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.